Clinical Trial Update: A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2, single-arm, multicenter exploratory trial is evaluating Adebrelimab plus Apatinib and systemic chemotherapy for initially unresectable biliary tract …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: Yongjun Chen | Conditions: Biliary Tract Cancer, Biliary Tract Cancer (CCA) | Phase 2 | Status: RECRUITING